Aegon to Divest U.K Protection Business

""
Securities In This Article
Aegon Ltd
(AGN)

Aegon AGN has announced the divestment of its U.K. individual protection business, but we don’t think this changes the company’s outlook. The divestment of the individual protection book includes life insurance, critical illness, and income protection policies for high-net-worth individuals that are customers. These Aegon products were sold to these 400,000 customers by independent financial advisers. While the financial terms of the deal have not been disclosed, strategically, management has long communicated a focus on retail and workplace savings in this market and has by and large been derisking critical illness. New life sales have been very low for some time in this part of Aegon’s business. As this does not alter the firm’s strategic direction and we anticipate it will not be a meaningful divestment, we maintain our fair value estimate and our rating of no economic moat.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Henry Heathfield, CFA

Equity Analyst
More from Author

Henry Heathfield, CFA, is an equity analyst, Europe, for Morningstar*. He focuses on researching, analysing and valuing insurance companies across Europe.

Heathfield joined Morningstar in 2016 as an equity analyst having spent eight years at Redmayne-Bentley and Silchester as a generalist in U.K. and Europe.

Heathfield holds a bachelor’s degree from Nottingham Trent University and a master’s degree in finance from London Business School. He also holds a CFA designation.

* Morningstar Holland BV (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc

Sponsor Center